• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BELLUS Health Inc

+ Add to Watchlist

BLUSF:US

1.5200 USD 0.1900 14.29%

As of 20:10:00 ET on 08/29/2014.

Snapshot for BELLUS Health Inc (BLUSF)

Open: 1.3257 Day's Range: 1.3164 - 1.5400 Volume: 16,333
Previous Close: 1.3300 52wk Range: 0.3320 - 1.5400 1-Yr Rtn: -

Stock Chart for BLUSF

No chart data available.
  • BLUSF:US 1.5200
  • 1D
  • 1M
  • 1Y
1.3300
Interactive BLUSF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BLUSF

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2013) -
Est. PEG Ratio -
Market Cap (M USD) 72.09
Shares Outstanding (M) 47.43
30 Day Average Volume 7,924
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BLUSF

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for BLUSF

BELLUS Health Inc. develops and commercializes therapeutics for neurological disorders. The Company has products in clinical trials for AA amyloidosis, the treatment of Alzheimer's Disease, and for the prevention of hemorrhagic stroke caused by amyloid angiopathy.

Roberto BelliniPresident/CEODenis GarceauSenior VP:Drug Development
Francois DesjardinsVP:FinanceTony MatzouranisVP:Business Development
More Company Profile & Key Executives for BLUSF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil